Now, it’s worth noting Stock Advisor's total average return is 1,072% — a market-crushing outperformance compared to 194% for ...

Astera Labs handily beat analyst estimates for the third quarter and guided higher than views for the current period. But ...

Rocket Lab’s stock (NASDAQ: RKLB) trended lower following the company's announcement to raise $750 million through equity dilution. This move, which increases the total number of shares, often ...

The space economy is projected to be a $1 trillion industry, offering significant long-term upside for Rocket Lab investors.

Rocket Lab is up more than 300% this year, and Wall Street is excited. Here's what I'm watching on Nov. 10 that could decide ...

Rocket Lab is gaining momentum as it prepares for the first Neutron launch, targeting a significant role in the US launch market. The new Virginia Launch Complex 3, purpose-built for Neutron, ...

Morgan Stanley just quadrupled its price target on Rocket Lab stock. The analyst calls Rocket Lab an early version of SpaceX. However, Rocket Lab stock costs 3x what SpaceX did at this stage in SpaceX ...

Rocket Lab shares have soared this year, fueled by the passage of a handful of milestones. Another major milestone will likely be met before the end of this year. From here, however, investors will ...

Shares of Rocket Lab Corp (NASDAQ:RKLB) are trading lower Wednesday afternoon, caught in a broader market downturn as major indices see red. Here’s what investors need to know. What To Know: The S&P ...

Potential Australian Clinical Labs Limited (ASX:ACL) shareholders may wish to note that the Independent Chairman, Stephen Roche, recently bought AU$193k worth of stock, paying AU$2.76 for each share.

Shares of Rocket Lab Corp (NASDAQ: RKLB) are trading marginally lower Friday. This week’s volatility was largely attributed to cautious remarks from Federal Reserve Chair Jerome Powell and rising oil ...